Biorestorative Therapies, INC. (BRTX) — 8-K Filings

8-K Filings (22)

• 8-K Filing — Apr 23, 2026
• BioRestorative Therapies Reports Q3 2025 Financials — Nov 12, 2025 Risk: medium
  BioRestorative Therapies, Inc. filed an 8-K on November 12, 2025, reporting its third quarter 2025 financial results. The filing also includes information on Re
• BioRestorative Therapies Files 8-K: Material Agreement & Equity Sales — Oct 8, 2025 Risk: medium
  On October 6, 2025, BioRestorative Therapies, Inc. entered into a material definitive agreement. The company also reported on unregistered sales of equity secur
• BioRestorative Therapies Holds Annual Meeting Vote — Sep 25, 2025 Risk: low
  BioRestorative Therapies, Inc. filed an 8-K on September 25, 2025, reporting on matters submitted to a vote of its security holders. The filing indicates that t
• BioRestorative Therapies 8-K Filing — Aug 14, 2025 Risk: low
  BioRestorative Therapies, Inc. filed an 8-K on August 14, 2025, reporting its status as a registrant. The filing confirms its principal executive offices are lo
• BioRestorative Therapies Files Q2 2025 8-K — Aug 12, 2025 Risk: medium
  BioRestorative Therapies, Inc. filed an 8-K on August 12, 2025, to report on its Q2 2025 earnings and provide a business update. The filing includes financial s
• 8-K Filing — Jun 13, 2025
• BioRestorative Therapies Q1 2025 Update — May 14, 2025 Risk: medium
  BioRestorative Therapies, Inc. announced its first quarter 2025 financial results and provided a business update on May 14, 2025. The company, formerly known as
• BioRestorative Therapies Changes Accountants — Apr 21, 2025 Risk: low
  BioRestorative Therapies, Inc. announced a change in its certifying accountant on April 16, 2025. The company's previous independent registered public accountin
• BioRestorative Therapies Reports 2024 Financials — Mar 27, 2025 Risk: medium
  BioRestorative Therapies, Inc. filed an 8-K on March 27, 2025, reporting financial results for the year ended December 31, 2024, and announcing a conference cal
• BioRestorative Therapies Files 8-K — Feb 10, 2025 Risk: low
  BioRestorative Therapies, Inc. filed an 8-K on February 10, 2025, reporting on its current activities. The filing primarily serves as a notification of informat
• 8-K Filing — Nov 13, 2024
• BioRestorative Therapies Files 8-K on Phase 2 Data — Nov 7, 2024 Risk: medium
  BioRestorative Therapies, Inc. filed an 8-K on November 7, 2024, reporting preliminary Phase 2 data and a review of its third-quarter conference call. The filin
• BioRestorative Therapies Terminates Agreement, Enters New Offering Deal — Nov 6, 2024 Risk: medium
  BioRestorative Therapies, Inc. announced on November 1, 2024, the termination of a material definitive agreement. The company also entered into a new material d
• BioRestorative Therapies Holds Shareholder Vote — Sep 23, 2024 Risk: medium
  BioRestorative Therapies, Inc. filed an 8-K on September 23, 2024, reporting on a matter submitted to a vote of its security holders on September 19, 2024. The
• BioRestorative Therapies Reports Q2 Results — Aug 13, 2024 Risk: low
  BioRestorative Therapies, Inc. filed an 8-K on August 13, 2024, to report its financial results for the second quarter. The filing details the company's operati
• BioRestorative Therapies Reports Q2 Results, Announces Conference Call — Aug 6, 2024 Risk: medium
  BioRestorative Therapies, Inc. filed an 8-K on August 6, 2024, reporting on its second quarter results and announcing a conference call. The filing details fina
• BioRestorative Therapies Restates Financials — May 24, 2024 Risk: medium
  BioRestorative Therapies, Inc. announced on May 23, 2024, that it will not rely on previously issued financial statements. This decision impacts financial repor
• BioRestorative Therapies Files 8-K with Presentation Materials — Mar 12, 2024 Risk: low
  On March 11, 2024, BioRestorative Therapies, Inc. filed an 8-K report. The filing primarily concerns the presentation materials related to the company's busines
• BRTX Raises $1M via Unregistered Stock & Warrant Sale — Feb 8, 2024 Risk: medium
  BioRestorative Therapies, Inc. (BRTX) entered into a material definitive agreement on February 6, 2024, for the unregistered sale of equity securities. This inv
• BRTX Files 8-K for Reg FD Disclosure, Exhibits on Feb 5 — Feb 5, 2024
  BioRestorative Therapies, Inc. (BRTX) filed an 8-K on February 5, 2024, to disclose information under Regulation FD and provide financial statements and exhibit
• BRTX Discloses Preliminary Phase 2 Clinical Trial Results via 8-K — Feb 1, 2024
  BioRestorative Therapies, Inc. (BRTX) filed an 8-K on February 1, 2024, to disclose a press release regarding preliminary results from its Phase 2 clinical tria

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX